According to previous reports, HCC rupture often occurs soon after the administration of anti-VEGF agents.9–11) When planning to administer atezo-bev to patients with HCC located on the liver surface, as in our case, TAE or TACE before the initiation of atezo-bev might be effective in preventing HCC rupture. This evidence concerns the gene VEGFA and hepatocellular carcinoma.